Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Enleofen Bio Pte Ltd
company
About
Enleofen is a developer of bio technology designed for the treatment of fibro-inflammatory diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Apr 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Enleofen is a developer of bio technology designed for the treatment of fibro-inflammatory diseases.The company is developing innovative, safe and highly effective therapeutics that address today's biggest healthcare challenges, enabling customers to access first-in-class antibody therapeutics for the treatment of fibrotic human diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Enleofen Bio Pte Ltd has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Apr 4, 2017 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 4, 2017 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Enleofen Bio Pte Ltd is funded by 1 investors.
Goodman Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Goodman Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
